These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 11335724)

  • 1. The amino acid residue at sequence position 5 in the conantokin peptides partially governs subunit-selective antagonism of recombinant N-methyl-D-aspartate receptors.
    Klein RC; Prorok M; Galdzicki Z; Castellino FJ
    J Biol Chem; 2001 Jul; 276(29):26860-7. PubMed ID: 11335724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subtype-selective antagonism of N-methyl-D-aspartate receptor ion channels by synthetic conantokin peptides.
    Sheng Z; Dai Q; Prorok M; Castellino FJ
    Neuropharmacology; 2007 Jul; 53(1):145-56. PubMed ID: 17588620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specific determinants of conantokins that dictate their selectivity for the NR2B subunit of N-methyl-D-aspartate receptors.
    Sheng Z; Prorok M; Castellino FJ
    Neuroscience; 2010 Oct; 170(3):703-10. PubMed ID: 20688135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The selectivity of conantokin-G for ion channel inhibition of NR2B subunit-containing NMDA receptors is regulated by amino acid residues in the S2 region of NR2B.
    Sheng Z; Liang Z; Geiger JH; Prorok M; Castellino FJ
    Neuropharmacology; 2009 Aug; 57(2):127-36. PubMed ID: 19427876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kinetic and mechanistic characterization of NMDA receptor antagonism by replacement and truncation variants of the conantokin peptides.
    Klein RC; Warder SE; Galdzicki Z; Castellino FJ; Prorok M
    Neuropharmacology; 2001 Dec; 41(7):801-10. PubMed ID: 11684144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Helix-helix interactions between homo- and heterodimeric gamma-carboxyglutamate-containing conantokin peptides and their derivatives.
    Dai Q; Sheng Z; Geiger JH; Castellino FJ; Prorok M
    J Biol Chem; 2007 Apr; 282(17):12641-9. PubMed ID: 17347154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-activity studies of conantokins as human N-methyl-D-aspartate receptor modulators.
    Nielsen KJ; Skjaerbaek N; Dooley M; Adams DA; Mortensen M; Dodd PR; Craik DJ; Alewood PF; Lewis RJ
    J Med Chem; 1999 Feb; 42(3):415-26. PubMed ID: 9986713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel conantokins from Conus parius venom are specific antagonists of N-methyl-D-aspartate receptors.
    Teichert RW; Jimenez EC; Twede V; Watkins M; Hollmann M; Bulaj G; Olivera BM
    J Biol Chem; 2007 Dec; 282(51):36905-13. PubMed ID: 17962189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of NMDA-induced currents by conantokin-G and conantokin-T in cultured embryonic murine hippocampal neurons.
    Klein RC; Galdzicki Z; Castellino FJ
    Neuropharmacology; 1999 Dec; 38(12):1819-29. PubMed ID: 10608277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of memantine on recombinant rat NMDA receptors expressed in HEK 293 cells.
    Bresink I; Benke TA; Collett VJ; Seal AJ; Parsons CG; Henley JM; Collingridge GL
    Br J Pharmacol; 1996 Sep; 119(2):195-204. PubMed ID: 8886398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ifenprodil discriminates subtypes of the N-methyl-D-aspartate receptor: selectivity and mechanisms at recombinant heteromeric receptors.
    Williams K
    Mol Pharmacol; 1993 Oct; 44(4):851-9. PubMed ID: 7901753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conantokin G is an NR2B-selective competitive antagonist of N-methyl-D-aspartate receptors.
    Donevan SD; McCabe RT
    Mol Pharmacol; 2000 Sep; 58(3):614-23. PubMed ID: 10953056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthetic analogues of conantokin-G: NMDA antagonists acting through a novel polyamine-coupled site.
    Zhou LM; Szendrei GI; Fossom LH; Maccecchini ML; Skolnick P; Otvos L
    J Neurochem; 1996 Feb; 66(2):620-8. PubMed ID: 8592132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NR2B-selective conantokin peptide inhibitors of the NMDA receptor display enhanced antinociceptive properties compared to non-selective conantokins.
    Xiao C; Huang Y; Dong M; Hu J; Hou S; Castellino FJ; Prorok M; Dai Q
    Neuropeptides; 2008; 42(5-6):601-9. PubMed ID: 18992939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sequence requirements for the N-methyl-D-aspartate receptor antagonist activity of conantokin-R.
    Blandl T; Zajicek J; Prorok M; Castellino FJ
    J Biol Chem; 2001 Mar; 276(10):7391-6. PubMed ID: 11096077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro and in vivo characterization of conantokin-R, a selective NMDA receptor antagonist isolated from the venom of the fish-hunting snail Conus radiatus.
    White HS; McCabe RT; Armstrong H; Donevan SD; Cruz LJ; Abogadie FC; Torres J; Rivier JE; Paarmann I; Hollmann M; Olivera BM
    J Pharmacol Exp Ther; 2000 Jan; 292(1):425-32. PubMed ID: 10604979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inducible expression and pharmacological characterization of recombinant rat NR1a/NR2A NMDA receptors.
    Kurkó D; Dezso P; Boros A; Kolok S; Fodor L; Nagy J; Szombathelyi Z
    Neurochem Int; 2005 Apr; 46(5):369-79. PubMed ID: 15737435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological properties of recombinant human N-methyl-D-aspartate receptors comprising NR1a/NR2A and NR1a/NR2B subunit assemblies expressed in permanently transfected mouse fibroblast cells.
    Priestley T; Laughton P; Myers J; Le Bourdellés B; Kerby J; Whiting PJ
    Mol Pharmacol; 1995 Nov; 48(5):841-8. PubMed ID: 7476914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Point mutations identify the glutamate binding pocket of the N-methyl-D-aspartate receptor as major site of conantokin-G inhibition.
    Wittekindt B; Malany S; Schemm R; Otvos L; Maccecchini ML; Laube B; Betz H
    Neuropharmacology; 2001 Nov; 41(6):753-61. PubMed ID: 11640930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NMDA receptor subunit-dependent modulation by conantokin-G and Ala7-conantokin-G.
    Ragnarsson L; Yasuda T; Lewis RJ; Dodd PR; Adams DJ
    J Neurochem; 2006 Jan; 96(1):283-91. PubMed ID: 16336218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.